Phase 1b/2 study to assess the clinical effects of BGB-290 in combination with radiation therapy (RT) and/or temozolomide (TMZ) in patients with first-line or recurrent/refractory glioblastoma
- Resource Type
- Journal
- Source
ANNALS OF ONCOLOGY ; SEP 2017, 28 1p. Supplement: 5- Subject
- Language
- English
- ISSN
- 15698041